Aviva Extends Founders Factory Partnership to Scale AI-Driven Fintech and Health Startups

Aviva, the UK's leading diversified insurer, today announces it is extending its exclusive fintech partnership with Founders Factory, the global venture studio and accelerator. Aviva is investing over three years to build new startups focusing on insurance, wealth, property, asset management and cybersecurity.

The new ventures will look to harness AI and frontier technologies to deliver new ways in how people manage and protect their money, health and family. The decade-long strategic partnership has supported more than 60 startups to date, which have raised more than £500 million in investment since 2016.

These include Tembo, a mortgage lending platform that recently saw Aviva expand access through its workplace pension proposition following a successful pilot, and Marrow, a connecter of AI agents including ChatGPT, Claude and Gemini to insurers’ pricing, underwriting and policy admin systems.

“Aviva’s long-standing partnership with Founders Factory is supporting new businesses to help customers and businesses manage and protect their money, health and family. Partnerships like ours show the power of innovation – they can boost UK investment and support economic growth, helping the UK get ready for the future.” said Arslan Hannani, Chief Innovation Officer, Aviva plc.

“Aviva's decade-long commitment marks one of the longest-standing corporate venture studio partnerships in the UK. The startups that spin out from the programme and continue to gather pace show what's possible when a financial services business chooses to keep innovating and moves the market forward. It proves that with time, a willingness to embrace new ideas, and a commitment to collaborating with the right founders, a venture studio can consistently produce category-defining companies.” said Henry Lane Fox, CEO of Founders Factory.

The Aviva x Founders Factory venture studio works with entrepreneurs to develop new ideas, technologies and business models, turning them into high-growth companies. Founders benefit from the unique access to Aviva's deep financial services expertise, alongside knowledge and data drawn from its millions of customers. This combined with preseed capital and Founders Factory's venture-building expertise unlocks a new generation of investable, high-impact companies that have the potential to transform markets and address some of the world’s biggest challenges.

Investments made by the Aviva x Founders Factory joint venture include Scan.com, a diagnostic imaging platform streamlining access to medical scans (which closed a £220M investment round in September 2026), Xapien, an AI-powered due diligence platform, and Valarian, a secure digital infrastructure and data sovereignty startup.